In addition, SRD5A2 was found to be aberrantly methylated in HCC tissues (20 cases) but not in any corresponding non-HCC liver tissues (20 cases), and served as a biomarker for early diagnosis of HCC [13, 14]. Here, SRD5A2 is linked to hepatocellular carcinoma.